|
TAF1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.014880E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.794000E-04 |
| Normal-vs-Stage2 |
3.900000E-01 |
| Normal-vs-Stage3 |
3.628400E-04 |
| Normal-vs-Stage4 |
7.55560000009758E-07 |
| Stage1-vs-Stage2 |
5.627500E-04 |
| Stage1-vs-Stage3 |
6.243800E-01 |
| Stage1-vs-Stage4 |
7.417800E-03 |
| Stage2-vs-Stage3 |
4.215200E-04 |
| Stage2-vs-Stage4 |
3.61999999998197E-06 |
| Stage3-vs-Stage4 |
2.595900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03749999999614E-05 |
| Normal-vs-AfricanAmerican |
1.300270E-02 |
| Normal-vs-Asian |
1.160270E-03 |
| Caucasian-vs-AfricanAmerican |
7.995000E-01 |
| Caucasian-vs-Asian |
6.128000E-01 |
| AfricanAmerican-vs-Asian |
5.433600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.577700E-04 |
| Normal-vs-Female |
3.382300E-04 |
| Male-vs-Female |
4.311800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.189610E-04 |
| Normal-vs-Age(41-60Yrs) |
5.804100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.023500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.910400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.370000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.925600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.616600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.512000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.621200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.757400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.357960E-01 |
| Classical-VS-Follicular |
7.71605002114484E-14 |
| Classical-VS-Other |
7.920800E-01 |
| Classical-VS-Normal |
9.43869999936453E-08 |
| Tall-VS-Follicular |
7.3068999961734E-08 |
| Tall-VS-Other |
6.404200E-01 |
| Tall-VS-Normal |
2.26519999999564E-05 |
| Follicular-VS-Other |
1.145610E-02 |
| Follicular-VS-Normal |
5.234200E-02 |
| Other-VS-Normal |
1.317910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550410E-01 |
| Normal-vs-N1 |
1.218960E-04 |
| N0-vs-N1 |
2.123100E-03 |
|
|
